Ronald Hurst, MD
Surgical Oncology · Los Angeles, CANPI 1619069820
Payments from drug & device makers
What this record shows
This record is dominated by education: $69,750 of the $76,062 with a category attached, or 91.7%. Intuitive Surgical accounts for 98.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $32,891 and has fallen 60.9% since, to $12,847 in 2025. Among surgical oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $845.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$75K
- Davol Inc.$342
- Boston Scientific$149
- BD$112
- Johnson & Johnson$64
- Merit Medical Systems Inc$54
- plus $225 from 8 others
What the payments were for
- Travel & lodging$1,2572%
- Food & beverage$5,0557%
- Education$69,75092%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 70 | $75,116 |
| Davol Inc. | 6 | $342 |
| Boston Scientific | 1 | $149 |
| BD | 1 | $112 |
| Johnson & Johnson | 2 | $64 |
| Merit Medical Systems Inc | 1 | $54 |
| Biom'up France SAS | 2 | $46 |
| Covidien LP | 1 | $45 |
| Conmed Corporation | 1 | $43 |
| Averitas Pharma Inc. | 1 | $23 |
| Leica Microsystems Inc. | 1 | $22 |
| Merck | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $16 |
| Convatec Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$73,676
- DAVINCI XI$750
- PHASIX$166
- GENERAL BPH$149
- PROGEL$112
How this compares
$76,062 in reported general payments places this provider in the 95th percentile of 209 surgical oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 34 | $62 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Los Angeles
- James EconomouLos Angeles$27K
- Cristina FerroneLos Angeles$25K
- Lee ZuckermanLos Angeles$19K
- Scott UmLos Angeles$16K
- Lawrence MenendezLos Angeles$13K
- Sujit KulkarniLos Angeles$11K
- Mediget TeshomeLos Angeles$9K
- Joshua EllenhornLos Angeles$9K
- Jason CohenLos Angeles$8K
- Afshin BahadorSan Diego$701K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.